Original ArticleCannabis Use Motivations among Adults Prescribed Opioids for Pain versus Opioid Addiction
Section snippets
Participants and Procedures
This study was a secondary analysis of data collected from December 2016 through April 2017 by the senior author that has been published previously (Bigand et al., 2019, Wilson et al., 2018). The parent study samples consisted of 300 total participants—150 from an OUD population and another 150 from a PP population. Participants were recruited from two outpatient opioid treatment programs and three pain clinics in Washington State, where medical and recreational cannabis use was legal at the
Descriptive Statistics
Among the 243 participants who reported ever having used marijuana, 9.9% of participants reported having a current medical marijuana registration and 50.2% of participants reported current, daily cannabis use. Adults with PP were significantly more likely to be older, female, and have higher levels of education compared with adults with OUD (Table 1). There were no significant differences between the populations on other demographic factors.
Reasons for Cannabis Use
Across the sample, 63% reported pain as a motivation
Discussion
Within this sample, adults who used opioids for PP and adults who used opioids for OUD differed significantly regarding cannabis use motivations related to enhancement and withdrawal. Both populations were motivated to use cannabis for several health-related reasons including pain, sleep, and anxiety. These findings are important for nursing care assessment and planning because the current prescribed opioid treatments may be insufficient for managing symptoms. Medicinal cannabis for PP has been
Acknowledgments
The authors wish to acknowledge Rebecca M. Craft, Ph.D., Department of Psychology, Washington State University, for her contributions as primary investigator on the Washington State University Grand Challenges Seed Grant that supported this subproject.
References (24)
- et al.
Reliability and validity of the Marijuana Motives Measure among young adult frequent cannabis users and associations with cannabis dependence
Addictive Behaviors
(2015) - et al.
Benefits and adverse effects of cannabis use among adults with persistent pain
Nursing Outlook
(2019) - et al.
Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain
The Journal of Pain
(2016) - et al.
Antecedents and consequences of cannabis use among racially diverse cannabis users: An analysis from ecological momentary assessment
Drug and Alcohol Dependence
(2015) - et al.
Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: Systematic review and meta-analysis
Social Science & Medicine
(2019) - et al.
Do medical marijuana laws reduce addictions and deaths related to pain killers?
Journal of Health Economics
(2018) - et al.
Cannabis in pain treatment: Clinical and research considerations
The Journal of Pain
(2016) - et al.
Use of marijuana exclusively for medical purposes
Drug and Alcohol Dependence
(2019) - et al.
Cannabis use moderates the relationship between pain and negative affect in adults with opioid use disorder
Addictive Behaviors
(2018) - et al.
Medical cannabis: An oxymoron? Physicians’ perceptions of medical cannabis
International Journal of Drug Policy
(2018)
Marijuana use motives: A confirmatory test and evaluation among young adult marijuana users
Addictive Behaviors
Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010
JAMA Internal Medicine
Cited by (14)
Shared Decision-Making for Patients Using Cannabis for Pain Symptom Management in the United States
2021, Pain Management NursingCitation Excerpt :Pain is the symptom reported most frequently by adults who report using cannabis for symptom management (Clem et al., 2020; Sexton et al., 2016). Co-occurring symptoms such as fatigue, sleep disturbance, and mood changes are often also targeted for relief with cannabis (Bigand et al., 2019; Clem et al., 2020). Because cannabis products may influence a number of pain-related symptoms including sleep, mood, and appetite (Bigand et al., 2019; Borgelt et al., 2013), it may not be feasible to determine through controlled experiments how cannabis affects wide varieties of pain conditions or clusters of symptoms.
The Role of Opioids in the Conundrum of Care for Persons in Pain
2020, Pain Management NursingCo-use of cannabis and prescription opioids in adults in the USA: a population-based, cross-sectional analysis of the NHANES from 2009 to 2018
2023, Regional Anesthesia and Pain MedicineUnderstanding feeling “high” and its role in medical cannabis patient outcomes
2023, Frontiers in PharmacologyPrevalence of marijuana use in pregnant women with concurrent opioid use disorder or alcohol use in pregnancy
2022, Addiction Science and Clinical Practice
This work was supported by Washington State University, United States (Grant no. WSU128515).